Chardan Capital Markets Starts Eyegate Pharmaceuticals (EYEG) at Buy
Tweet
Share
E-mailGet Alerts EYEG Hot Sheet
Price: $34.60 -0.32%
Rating Summary:
4 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 5 | New: 3
Rating Summary:
4 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 5 | New: 3
Join SI Premium – FREE
Chardan Capital Markets initiated coverage on Eyegate Pharmaceuticals (NASDAQ: EYEG) with a Buy rating and a price target of $6.00.
For an analyst ratings summary and ratings history on Eyegate Pharmaceuticals click here. For more ratings news on Eyegate Pharmaceuticals click here.
Shares of Eyegate Pharmaceuticals closed at $2.47 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BioLineRx plans $3.75M share offering at $2.78 per ADS
- CLSA Starts Meesho Ltd (MESSHO:IN) at Underperform (4)
- Kepler Cheuvreux Resumes Gerresheimer AG (GXI:GR) (GRRMF) at Reduce
Create E-mail Alert Related Categories
New CoverageRelated Entities
Chardan Capital MarketsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
